Company Filing History:

10 out of 10,754

Basf Aktiengesellschaft

patents

3 out of 4,177

Abbott Laboratories Corporation

Years Active: 1995-2011

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7863444 - 4-aminopyrrolopyrimidines as kinase inhibitors (2011-01-04),

2. 6713474 - Pyrrolopyrimidines as therapeutic agents (2004-03-30),

3. 6444674 - Substituted pyrimidine compounds and the use thereof (2002-09-03),

4. 6403593 - Triazole compounds and the use thereof (2002-06-11),

5. 6342604 - Substitute pyrimidine compounds and the use thereof (2002-01-29),

6. 6328855 - Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes (2001-12-11),

7. 6124294 - Triazole compounds and the use thereof (2000-09-26),

8. 6028073 - N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as (2000-02-22),

9. 6001839 - Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors (1999-12-14),

10. 5908844 - N-substituted azabicycloalkane derivatives, their preparation and use (1999-06-01),

11. 5753690 - N-substituted azobicycloheptane derivatives, the preparation and use (1998-05-19),

12. 5703091 - N-substituted azabicycloalkane derivatives, their preparation and use (1997-12-30),

13. 5616705 - N-substituted azabicycloheptane derivatives, their preparation and use (1997-04-01),

14. 5475105 - N-substituted azabicycloheptane derivatives (1995-12-12),

Title: Rainer Munschauer: Innovator in Kinase Inhibitors

Introduction

Rainer Munschauer is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of chemical compounds, particularly in the development of kinase inhibitors. With a total of 14 patents, Munschauer's work has the potential to impact various medical conditions.

Latest Patents

One of Munschauer's latest patents involves 4-aminopyrrolopyrimidines as kinase inhibitors. These chemical compounds, along with their physiologically acceptable salts, serve as inhibitors of serine/threonine and tyrosine kinase activity. The kinases inhibited by these compounds are crucial in immunologic, hyperproliferative, or angiogenic processes. Consequently, these compounds can be utilized to treat cancer, hyperproliferative disorders, rheumatoid arthritis, immune system disorders, transplant rejection, and inflammatory disorders.

Career Highlights

Throughout his career, Munschauer has worked with prominent companies such as BASF Aktiengesellschaft and Abbott Laboratories Corporation. His expertise in the field has led to the development of innovative therapeutic agents that address critical health issues.

Collaborations

Munschauer has collaborated with notable colleagues, including Liliane Unger and Gerd Steiner. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Rainer Munschauer's contributions to the field of kinase inhibitors highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for new treatments in various medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.